EIF5
Eukaryotic translation initiation factor 5
Also known as: IF5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55010
- Gene
- EIF5
- Ensembl
- ENSG00000100664
- Chromosome
- 14
- Canonical length
- 431 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Eukaryotic translation initiation factor-5 (EIF5) interacts with the 40S initiation complex to promote hydrolysis of bound GTP with concomitant joining of the 60S ribosomal subunit to the 40S initiation complex. The resulting functional 80S ribosomal initiation complex is then active in peptidyl transfer and chain elongations (summary by Si et al., 1996 [PubMed 8663286]).[supplied by OMIM, May 2010]
Canonical amino-acid sequenceUniProt
431 residues, UniProt reviewed canonical sequence.
>P55010|EIF5
1 MSVNVNRSVS DQFYRYKMPR LIAKVEGKGN GIKTVIVNMV DVAKALNRPP TYPTKYFGCE
61 LGAQTQFDVK NDRYIVNGSH EANKLQDMLD GFIKKFVLCP ECENPETDLH VNPKKQTIGN
121 SCKACGYRGM LDTHHKLCTF ILKNPPENSD SGTGKKEKEK KNRKGKDKEN GSVSSSETPP
181 PPPPPNEINP PPHTMEEEED DDWGEDTTEE AQRRRMDEIS DHAKVLTLSD DLERTIEERV
241 NILFDFVKKK KEEGVIDSSD KEIVAEAERL DVKAMGPLVL TEVLFNEKIR EQIKKYRRHF
301 LRFCHNNKKA QRYLLHGLEC VVAMHQAQLI SKIPHILKEM YDADLLEEEV IISWSEKASK
361 KYVSKELAKE IRVKAEPFIK WLKEAEEESS GGEEEDEDEN IEVVYSKAAS VPKVETVKSD
421 NKDDDIDIDA ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 184 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 184 nTPM
- skeletal muscle: 153 nTPM
- liver: 141 nTPM
- tongue: 135 nTPM
- testis: 89 nTPM
- thyroid gland: 88 nTPM
Single-cell type
- late spermatids: 1,163 nCPM
- esophageal apical cells: 835 nCPM
- epididymal basal cells: 649 nCPM
- syncytiotrophoblasts: 634 nCPM
- late primary spermatocytes: 565 nCPM
- esophageal suprabasal cells: 486 nCPM
Immune cell
- total PBMC: 396 nTPM
- basophil: 351 nTPM
- memory B-cell: 328 nTPM
- naive B-cell: 328 nTPM
- plasmacytoid DC: 324 nTPM
- eosinophil: 320 nTPM
Brain region
- white matter: 126 nTPM
- spinal cord: 114 nTPM
- hypothalamus: 106 nTPM
- midbrain: 104 nTPM
- pons: 103 nTPM
- cerebellum: 100 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.56
- DepMap mean gene effect
- -1.4
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- formation of cytoplasmic translation initiation complex
- regulation of translational initiation
- ribosome assembly
Molecular functions
- cadherin binding
- eukaryotic initiation factor eIF2 binding
- GDP-dissociation inhibitor activity
- GTP binding
- GTPase activator activity
- RNA binding
- translation initiation factor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF5 as an antibody target. Whether an autoantibody or antibody against EIF5 could matter depends on whether native EIF5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EIF5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...